China channel feed

Leg­end scraps tri­al of its fol­low-up au­tol­o­gous CAR-T weeks af­ter clin­i­cal hold was lift­ed

3 years ago
R&D
Cell/Gene Tx

Two months af­ter CRL, FDA ac­cepts Co­herus, Jun­shi's re­sub­mis­sion for PD-1 stud­ied in Chi­na

3 years ago
FDA+

With Lil­ly's back­ing, a CRO with roots in Chi­na bags $150M round to fu­el glob­al growth

3 years ago
Financing
Outsourcing

No­var­tis, BeiGene lay out front­line PhI­II da­ta for PD-1 drug as sec­ond-line PDU­FA date looms

3 years ago
R&D
Pharma

Am­gen takes next step with its Chi­na am­bi­tions, out-li­cens­ing drugs to Fo­s­un Phar­ma

3 years ago
Pharma

Scoop: Lit­tle-known Or­biMed-backed biotech clos­es $160M round to start gene ther­a­py tri­al

3 years ago
Financing
Startups

F-star bought out in $161M all-cash deal as Hong Kong's Sino Bio­pharm looks to­ward in­ter­na­tion­al ex­pan­sion

3 years ago
Deals

As­traZeneca con­tin­ues to build out its pres­ence in Chi­na with new COPD drug man­u­fac­tur­ing site

3 years ago
Manufacturing

Boehringer In­gel­heim to in­cu­bate biotechs with Hong Kong R&D leader

3 years ago
Startups

#AS­CO22: A small Chi­na biotech play­er makes its de­but at AS­CO with promis­ing da­ta on its GPRC5D mul­ti­ple myelo­ma drug

3 years ago
Bioregnum

#AS­CO22: Leg­end, J&J say Carvyk­ti holds up past the two-year mark as pair preps for po­ten­tial sec­ond nod

3 years ago
R&D
Cell/Gene Tx

Se­quoia Chi­na leads $37M in­fu­sion in­to ra­dio­phar­ma­ceu­ti­cals play­er set­ting up shop in Chi­na and Bel­gium

3 years ago
Financing
Startups

House Re­pub­li­cans at­tack Chi­na-on­ly da­ta in FDA sub­mis­sions, seek new in­ves­ti­ga­tion in­to re­search in­spec­tions

4 years ago
FDA+

As GSK-part­nered Covid an­ti­body racks up glob­al sales, Vir ax­es WuXi deal and grabs back Chi­na rights

4 years ago
Deals
Coronavirus

Fu­ji­film con­tin­ues its biotech build­ing spree with new fa­cil­i­ty in Chi­na

4 years ago
Pharma
Manufacturing

Chi­nese phar­ma gi­ant Hen­grui launch­es new com­pa­ny for glob­al­iza­tion play — with a Mer­ck KGaA vet at the helm

4 years ago
Startups

Un­der-the-radar Chi­nese biotech scores $47M up­front in se­cre­tive Mer­ck deal around can­cer drug

4 years ago
Deals

Chi­nese Alzheimer's drug­mak­er says lack of fund­ing, Covid out­break forced it to shut­ter in­ter­na­tion­al PhI­II

4 years ago
R&D

Star­na Ther­a­peu­tics emerges with fi­nanc­ing for mR­NA vac­cine and ther­a­pies

4 years ago
Financing
Startups

Scoop: Green Val­ley's sea­weed-de­rived Alzheimer's drug, ap­proved in Chi­na, is halt­ed in PhI­II study

4 years ago
R&D
Pharma

SEC shines reg­u­la­to­ry spot­light on I-Mab, Sino­vac and oth­ers as more Chi­nese biotechs scram­ble to com­ply with new law

4 years ago
FDA+

Frank Zhang is in the clear af­ter Chi­nese au­thor­i­ties con­clude in­ves­ti­ga­tion with­out charges, com­pa­ny says

4 years ago
People
Law

FDA hits Hutchmed, Jun­shi drugs with CRLs — fur­ther clar­i­fy­ing its stance on Chi­na-on­ly da­ta

4 years ago
FDA+

No­var­tis records an­oth­er tislelizum­ab win en route to bring­ing BeiGene's PD-1 to FDA's doors

4 years ago
R&D
Pharma
First page Previous page 9101112131415 Next page Last page
A service from the Financial Times